Skip to content
Innovative Tech
Diseases
Health Policy
HTA
Data Analysis
Clinical Practice
Contributors
BACK TO MAIN SITE
New Innovations in Elderly Healthcare: Latest P...
By
HEOR Staff Writer
September 4, 2024
Introduction The Pharmaceutical Benefits Advisory Committee (PBAC) has recently published its latest outcomes, which include several new drug listing...
Efficacy of Early Intensive Behavioural Intervention for Autism
Addressing the Challenges of Value Attribution in Combination Therapies
Extension of BowelScreen to Ages 50-54: A Cost-Effectiveness Analysis
The Use of Target Product Profiles in Health Technology Development
Revealing the Hidden Impact: Family Spillover Effects
Transformation of Health Technology Assessment in Türkiye
The Role of Pull Incentives in Addressing Antimicrobial Resistance
The Shift to Value-Based Drug Pricing in the United States
Quality-Adjusted Life Year (QALY) in Modern Healthcare Decision-Making
Self-Management of Vaginal Pessaries: A Viable Alternative for Pelvic Organ P...
The Shifting Nature and Impact of Health Technology Assessment
Managing Access to Medicines in the Future: Innovations and Strategies
« Previous
1
2
3
4
5
6
…
9
Next »